$3.26 billion in sales expected for Universal Health Services, Inc. (NYSE: UHS) this quarter


Stock analysts expect Universal Health Services, Inc. (NYSE:UHS – Get a rating) will announce sales of $3.26 billion for the current fiscal quarter, according to Zacks. Four analysts provided earnings estimates for Universal Health Services, with the lowest sales estimate of $3.22 billion and the highest estimate of $3.30 billion. Universal Health Services posted sales of $3.01 billion in the same quarter last year, which would indicate a positive year-over-year growth rate of 8.3%. The company is due to release its next earnings report on Monday, January 1.

According to Zacks, analysts expect Universal Health Services to report revenue of $13.49 billion in the current fiscal year, with estimates ranging from $13.42 billion to $13.57 billion. of dollars. For the next fiscal year, analysts expect the company to post sales of $14.07 billion, with estimates ranging from $13.87 billion to $14.22 billion. Zacks Investment Research sales averages are an average based on a survey of analysts who track Universal Health Services.

Universal Health Services (NYSE: UHS – Get a rating) last released its results on Thursday, February 24. The healthcare services provider reported earnings per share (EPS) of $2.95 for the quarter, beating Thomson Reuters consensus estimate of $2.83 by $0.12. The company posted revenue of $3.28 billion for the quarter, versus analyst estimates of $3.13 billion. Universal Health Services had a return on equity of 15.41% and a net margin of 7.84%. The company’s revenue increased 6.1% year over year. During the same period a year earlier, the company posted earnings per share of $3.59.

(A d)

Strong management, innovative products – this company won’t stay under the radar for long

Several research companies have recently commented on the UHS. Mizuho raised its target price on Universal Health Services from $151.00 to $164.00 and gave the stock a “buy” rating in a Thursday, March 3 research report. UBS Group raised its target price on Universal Health Services from $124.00 to $134.00 and gave the stock a “sell” rating in a Monday, March 7 research report. TheStreet upgraded universal health services from a “c+” grade to a “b-” grade in a research report on Monday, December 27. Citigroup raised its target price on Universal Health Services from $162.00 to $167.00 in a Tuesday, March 1 research report. Finally, SVB Leerink raised its price target on Universal Health Services from $136.00 to $139.00 and gave the stock a “market performance” rating in a Monday, February 28 research report. . Three equity research analysts gave the stock a sell rating, four issued a hold rating and five gave the company a buy rating. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $156.00.

Separately, director Lawrence S. Gibbs sold 1,307 shares of the company in a transaction dated Friday, March 11. The stock was sold at an average price of $153.00, for a total value of $199,971.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, available at the SEC website. Additionally, director Eileen C. Mcdonnell sold 296 shares of the company in a transaction that took place on Monday, February 28. The shares were sold at an average price of $141.17, for a total value of $41,786.32. Disclosure of this sale can be found here. Insiders hold 13.40% of the shares of the company.

A number of large investors have recently increased or reduced their stakes in UHS. Allspring Global Investments Holdings LLC purchased a new stake in Universal Health Services in the fourth quarter valued at $188,455,000. Nordea Investment Management AB increased its holding in shares of Universal Health Services by 90.4% during the third quarter. Nordea Investment Management AB now owns 2,248,212 shares of the healthcare provider valued at $321,675,000 after buying an additional 1,067,340 shares last quarter. Nuance Investments LLC increased its holdings of Universal Health Services stock by 150.6% during the 4th quarter. Nuance Investments LLC now owns 1,750,343 shares of the healthcare provider valued at $226,949,000 after buying an additional 1,051,850 shares last quarter. Morgan Stanley increased its stake in shares of Universal Health Services by 619.5% during the second quarter. Morgan Stanley now owns 894,528 shares of the healthcare provider valued at $130,985,000 after buying an additional 770,198 shares last quarter. Finally, Norges Bank purchased a new equity stake in Universal Health Services during Q4 for $92,187,000. Institutional investors and hedge funds hold 86.00% of the company’s shares.

NYSE UHS shares opened at $143.81 on Thursday. The stock has a market capitalization of $10.76 billion, a PE ratio of 12.17, a growth price-earnings ratio of 1.26 and a beta of 1.06. Universal Health Services has a minimum of $116.23 over fifty-two weeks and a maximum of $165.00 over fifty-two weeks. The company has a debt ratio of 0.67, a quick ratio of 1.04 and a current ratio of 1.14. The stock has a fifty-day moving average of $138.37 and a 200-day moving average of $134.57.

Universal Health Services announced that its board of directors authorized a stock repurchase plan on Thursday, Feb. 24 that allows the company to repurchase $1.40 billion in stock. This repurchase authorization authorizes the health service provider to repurchase up to 12.1% of its shares through open market purchases. Stock buyback plans are usually an indication that the company’s management believes its stock is undervalued.

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 15. Shareholders of record on Tuesday, March 1 received a dividend of $0.20. This represents a dividend of $0.80 on an annualized basis and a dividend yield of 0.56%. The ex-dividend date was Monday, February 28. Universal Health Services’ dividend payout ratio (DPR) is currently 6.77%.

About Universal Health Services (Get a rating)

Universal Health Services, Inc. operates as a healthcare management company that, through its subsidiaries, owns and operates acute care hospitals, behavioral health centers and outpatient care facilities. It operates through the following segments: Acute Care Hospital Services, Behavioral Health Care Services and Others.

Featured Articles

Get a Free Copy of Zacks’ Research Report on Universal Health Services (UHS)

For more information on Zacks Investment Research’s research offerings, visit Zacks.com

History and revenue estimates for universal health services (NYSE: UHS)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in universal health services right now?

Before you consider universal health services, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated, top-performing research analysts daily and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Universal Health Services was not on the list.

While Universal Health Services currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here


Comments are closed.